Linagliptin CAS: 668270-12-0 Chaw tsim tshuaj paus
Linagliptin (TrajentaR, TradjentaTM, TrazentaTM, TrayentaTM) yog qhov ncauj, xaiv ntau yam inhibitor ntawm dipeptidyl peptidase-4 thiab yog thawj tus neeg sawv cev ntawm nws cov chav kawm kom tshem tawm feem ntau ntawm txoj hauv kev tsis muaj lub raum.Linagliptin yog siv rau ib hnub ib zaug rau kev kho mob ntawm cov neeg laus uas muaj ntshav qab zib hom 2.Linagliptin ua kom txo cov ntshav qabzib hauv cov ntshav los ntawm inhibiting cov enzyme DPP-4, yog li tiv thaiv kev degradation ntawm cov tshuaj hormones incretin (glucagon-zoo li peptide-1 [GLP]. -1] thiab glucose-dependent insulinotropic peptide) thiab txo qis cov piam thaj tom qab kev mus ncig.
Kev sib xyaw | C25H28N8O2 |
Assay | 99% |
Qhov tshwm sim | Dawb hmoov |
CAS Nr. | 668270-12-0 |
Ntim | 25 KG |
Txee lub neej | 2 xyoo |
Cia | Khaws rau hauv qhov chaw txias thiab qhuav |
Daim ntawv pov thawj | ISO. |
Sau koj cov lus ntawm no thiab xa tuaj rau peb